DAFTAR PUSTAKA

1. World Health Organization. World Cancer Report 2014. IARC 2015

2. World Health Organization. International Agency for Research on Cancer.
GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevaence
Worldwide in 2012. Lung Cancer. Diakses 2 Mei 2015
3. Quaresma M, Coleman MP, Rachet B2. 40-year trends in an index of
survival for all cancers combined and survival adjusted for age and sex for
each cancer in England and Wales, 1971-2011: a population-based study.
Lancet 2014;6736(14):61396-9.
4. Cancer Research UK. Breast Cancer Statistics. CRUK 2015. Diakses: 2
Mei 2015
5. Krigjsman O, Roepman P, Zwart W, dkk. A diagnostic gene profile for
molecular subtyping of breast cancer associated with treatment response.
Breast Cancer Res Treat 2011; 1007:10549-11
6. Wiguna WIP, Manuaba IB. Karakteristik Pemeriksaan Imunohistokimia
pada Pasien Kanker Payudara di RSUP Sanglah Periode 2003-2012. Ejournal medika udayana 2014; 3(7):1-13
7. Badve S, Dabbs DJ, Schnitt SJ, dkk. Basal-like and triple-negative breast
cancers: a critical review with an emphasis on the implications for
pathologists and oncologists. Modern Pathology 2011;24:157167
8. Fitzgibbons PL, Page DL, Weaver D, dkk. Prognostic factors in breast
cancer. College of American Pathologists Consensus Statement 1999. Arch
Pathol Lab Med. 2000;124(7):966-78.
9. Bombonati A, Sgroi DC. The Molecular Pathology of Breast Cancer
Progression. J Pathol. 2011; 223(2): 307317
10. Gonzales CD, Alvarez S, Ropolo A, dkk. Autophagy, Warburg, and
Warburg Reverse Effects in Human Cancer. BioMed Research
International 2014:1-10

11. Ko YH, Verhoeven HA, Lee MJ, Corbin DJ, Vogl TJ, Pedersen PL. A
translational study "case report" on the small molecule "energy blocker" 3bromopyruvate (3BP) as a potent anticancer agent: from bench side to
bedside. J Bioenerg Biomembr. 2012 F;44(1):163-70
12. Nakayama Y, Torigoe T, Inoue Y, dkk. Prognostic significance of
monocarboxylate transporter 4 expression in patients with colorectal
cancer. Exp and Ther Med 2012;3:25-30
13. Wietkiwicz AK, Menezes DW, Dasgupta A, dkk. Stromal MCT4 predicts
poor clinical outcome in triple-negative breast cancers. Cell Cycle
2012;11(6), 1108-1117
14. Sunaga N, Miyajima K, Suzuki M, dkk. Different Roles for Caveolin-1 in
the Development of Non-Small Cell Lung Cancer versus Small Cell Lung
Cancer. CANCER RESEARCH 2004; 64 42774285
15. Helgans S, Cordes N. Caveolin-1: an essential modulator of cancer cell
radio- and chemoresistance. Am J Cancer Res 2011;1(4):521-530
16. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin.
2015;65(1):5-29.
17. Stopeck A, Sparano JA, Harris JE. Breast Cancer Overview. Updated 31
March

2015.

Website:

http://emedicine.medscape.com/article/1947145-overview.

http://www.
Medscape

Reference. Akses 2 Mei 2015.

18. Kumar, Vinay; Abul Abbas. 2010. Robbins and Cotran Pathologic Basis
of Disease. Philadelphia: Saunders, an imprint of Elsevier inc.
Halaman 1090
19. The Cancer Genome Atlas Network (TCGA). Comprehensive molecular
portraits of human breast tumours. Nature. Oct 4 2012;490(7418):61-70.
20. Sotiriou C, Pusztai L. "Gene-expression signatures in breast cancer". N.
Engl. J. Med. 2009:360(8): 790800

21. Elmore JG, Armstrong K, Lehman CD, Fletcher SW. Screening for breast
cancer. JAMA. 2005;293(10):1245-56
22. Saini KS, Taylor C, Ramirez AJ, Palmieri C, Gunnarsson U, et all. "Role
of the multidisciplinary team in breast cancer management: results from a
large international survey involving 39 countries". Annals of Oncology.
2011:23(4): 8539
23. Vaidya JS, Joseph DJ, Tobias JS, Bulsara M, Wenz F, et all. "Targeted
intraoperative radiotherapy versus whole breast radiotherapy for breast
cancer (TARGIT-A trial): an international, prospective, randomised, noninferiority phase 3 trial". Lancet.2010:376(9735):91102
24. Robb C, Haley WE, Balducci L, Extermann M, Perkins EA, Small BJ,
Mortimer J. "Impact of breast cancer survivorship on quality of life in
older women". Critical Reviews in Oncology/hematology 2007:62(1):84
91
25. Austin, E. D., Mal, L., LeDuc, C., Rosenzweig, E. B., Borczuk, A.,
Phillips, J. A., III, Palomero, T., Sumazin, P., Kim, H. R., Talati, M. H.,
West, J., Loyd, J. E., Chung, W. K. Whole exome sequencing to identify a
novel gene (caveolin-1) associated with human pulmonary arterial
hypertension. Circ. Cardiovasc. Genet. 2012:5: 336-343
26. Hehlgans S, Cordes N. Caveolin-1: An essential modulator of cancer cell
radio and chemoresistance. American Journal of Cancer Research.
2011:1(4):521-530
27. Chidlow JH, Jr. and Sessa WC. Caveolae, caveolins, and cavins: complex
control of cellular signalling and inflammation. Cardiovasc Res 2010; 86:
219-225.
28. Liu P, Rudicks M, Anderson RG. Multiple Functions of Caveolin-1. The
Journal of Biological Chemistry. 2002:277(44);41295-8
29. Halestrap AP, Price NT (Oct 1999). "The proton-linked monocarboxylate
transporter (MCT) family: structure, function and regulation". The
Biochemical Journal. 1999:343(2):281299

30. Gonzales LL, Aguiar L, Diaz J, dkk. E-cadherin determines Caveolin-1

tumor suppression or metastasis enhancing function in melanoma cells.

Pigment Cell Melanoma Res. 2013; 26(4): 555570